Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cord Blood America's total revenue decreases 3% to $1.42 million in Q1 2014

Cord Blood America's total revenue decreases 3% to $1.42 million in Q1 2014

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

EntreMed reports net loss of $1.5M in first quarter 2014

EntreMed reports net loss of $1.5M in first quarter 2014

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

Research offers potential for future treatment of childhood acute lymphoblastic leukemia

Research offers potential for future treatment of childhood acute lymphoblastic leukemia

New study presents novel strategy for treating multiple myeloma

New study presents novel strategy for treating multiple myeloma

Researchers use molecular diagnostic methods to detect cancer

Researchers use molecular diagnostic methods to detect cancer

Foundation Medicine obtains CE mark for FoundationOne

Foundation Medicine obtains CE mark for FoundationOne

Study of rare childhood neurodegenerative diseases identifies new source of DNA damage

Study of rare childhood neurodegenerative diseases identifies new source of DNA damage

Researchers discover new mechanism that distinguishes normal blood stem cells from blood cancers

Researchers discover new mechanism that distinguishes normal blood stem cells from blood cancers

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

New technique expands number of functional cord blood stem cells for transplantation

New technique expands number of functional cord blood stem cells for transplantation

ARIAD provides update on corporate developments, reports Q1 2014 financial results

ARIAD provides update on corporate developments, reports Q1 2014 financial results

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva's SYNRIBO for injection receives FDA approval for home administration

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

NCCN publishes new patient resource for stage 0 breast cancer

NCCN publishes new patient resource for stage 0 breast cancer

MEI Pharma begins ME-344 Phase Ib clinical study in patients with solid tumors

MEI Pharma begins ME-344 Phase Ib clinical study in patients with solid tumors

Virginia researchers develop new combination therapy that could potentially treat multiple myeloma

Virginia researchers develop new combination therapy that could potentially treat multiple myeloma

RDT receives FDA approval for new liquid form of treatment for patients with ALL

RDT receives FDA approval for new liquid form of treatment for patients with ALL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.